Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Common painkiller may also be powerful cancer killer
WASHINGTON, Jan.
‘New’ drug for colorectal cancer
PRIMA-1metResearchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have demonstrated that an existing drug gives promising results in the treatment of colorectal cance...
AstraZeneca And Incyte Announce New Lung Cancer Clinical Trial Collaboration
AstraZeneca and Incyte Corporation today announced a new collaboration to evaluate the efficacy and safety of Incyte’sJanus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination wit...
Immune Pharmaceuticals Announces 2016 Immuno-Oncology Plan
NEW YORK, Jan.
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program
KENILWORTH, NJ, USA I January 11, 2016 I Merck (NYSE.
Good Bacteria May Help Prevent Pneumonia, Says New Study
NEW YORK.
Sanofi and Regeneron line up for FDA approval with an arthritis treatment
Sanofi ($SNY) and Regeneron ($REGN) are moving toward FDA approval with what could be their second blockbuster collaboration, preparing to make the case for a new treatment for rheumat...
Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products
HERTFORDSHIRE, England and PITTSBURGH, Jan.
Takeda and NsGene Partner to Perform Research in Cell Encapsulation Therapies for Parkinson's Disease
Osaka, Japan, January 8, 2016, and Providence, RI; January 7, 2016 – Takeda Pharmaceutical Company Limited (TSE.
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection
SofosbuvirVelpatasvirFOSTER CITY, Calif.
Lupin gets FDA nod for generic Femhrt tablets
Drug major Lupin has received US health regulator’s approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
WOODCLIFF LAKE, N.
619
620
621
622
623
624
625
626
627
